These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4690434)

  • 1. [Medroxyprogesterone acetate administered intramuscularly every third month as a contraceptive. An investigation of the efficacy, side effects and acceptability].
    Marker IL
    Ugeskr Laeger; 1973 Feb; 135(6):294-7. PubMed ID: 4690434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medroxprogestrone acetate as a contraceptive].
    Hornemann B; Osler M
    Ugeskr Laeger; 1973 Feb; 135(6):289-94. PubMed ID: 4690433
    [No Abstract]   [Full Text] [Related]  

  • 3. Parenteral medroxyprogesterone as a contraceptive agent.
    Scutchfield FD; Long WN
    Public Health Rep (1896); 1969 Dec; 84(12):1059-62. PubMed ID: 4982071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of Depo Provera as a contraceptive in the puerperium].
    Narducci U; Piatti N
    Minerva Ginecol; 1973 Feb; 25(2):107-11. PubMed ID: 4735312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use-effectiveness of six-month injections of DMPA as a contraceptive.
    McDaniel EB; Pardthaisong T
    Am J Obstet Gynecol; 1974 May; 119(2):175-80. PubMed ID: 4823385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive use--efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days.
    Schwallie PC; Assenzo JR
    Fertil Steril; 1973 May; 24(5):331-9. PubMed ID: 4698589
    [No Abstract]   [Full Text] [Related]  

  • 7. [Injectable contraceptives. 10 years' clinical experience].
    Cervantes A; Gorodovsky J; Maqueo M
    Ginecol Obstet Mex; 1973 Oct; 34(204):369-81. PubMed ID: 4272910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent].
    Linthorst G; Wibaut EP; de Jongh RE
    Ned Tijdschr Geneeskd; 1972 Sep; 116(38):1694-8. PubMed ID: 5069858
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of injectable contraceptive immediately post partum.
    Jones JR; Lonky S
    N Y State J Med; 1971 Oct; 71(19):2279-82. PubMed ID: 5315289
    [No Abstract]   [Full Text] [Related]  

  • 10. Intramuscular depomedroxyprogesterone acetate for contraception.
    Koetsawang S; Srisuphandit S; Srivanaboon S; Bhiraleus P; Rachawat D; Kiriwat O; Koetsawang A
    J Med Assoc Thai; 1974 Aug; 57(8):396-406. PubMed ID: 4413964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contraception with the 3-months injection].
    Hauser GA
    Ther Umsch; 1972 May; 29(5):310-3. PubMed ID: 5064704
    [No Abstract]   [Full Text] [Related]  

  • 12. Depo-medroxyprogesterone acetate as a contraceptive.
    Seymour RJ; Powell LC
    Obstet Gynecol; 1970 Oct; 36(4):589-96. PubMed ID: 5506464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative contraceptive experience with three-month and six-month medroxyprogesterone acetate regimens.
    Rall HJ; van Niekerk WA; Engelbrecht BH; van Schalkwyk DJ
    J Reprod Med; 1977 Feb; 18(2):55-60. PubMed ID: 833802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting contraception. A brief report.
    Tipton HB
    Rocky Mt Med J; 1972 Nov; 69(11):44-5. PubMed ID: 4638612
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
    Ringrose CA
    J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with contraceptive effect of Depo-Provera, 300mg and 450mg, administered in 6-month intervals].
    Havránek F; Tichý M; Divila F; Hejda V
    Cesk Gynekol; 1972 Mar; 37(2):95-6. PubMed ID: 5023983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraception with a six-monthly injection of progestogen. 1. Effects on blood pressure, body weight and uterine bleeding pattern, side-effects, efficacy, and acceptability.
    Mackay EV; Khoo SK; Adam RR
    Aust N Z J Obstet Gynaecol; 1971 Aug; 11(3):148-56. PubMed ID: 5286756
    [No Abstract]   [Full Text] [Related]  

  • 18. Depo-medroxyprogesterone acetate as a contraceptive agent: its effect on weight and blood pressure.
    Leiman G
    Am J Obstet Gynecol; 1972 Sep; 114(1):97-102. PubMed ID: 4637044
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent.
    Jeppsson S
    Acta Obstet Gynecol Scand; 1972; 51(3):257-63. PubMed ID: 5072161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of medroxyprogesterone as a contraceptive agent].
    Brun G; Deloitte H; Laffont C
    Rev Fr Gynecol Obstet; 1972 Jan; 67(1):67-75. PubMed ID: 4559969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.